Insider Daniel Pietrzak saw enough value to buy 5,000 shares of FS KKR Capital at $11.25 apiece on February 27, a vote of confidence from management that stands in stark contrast to the market’s verdict. The stock has since tumbled another 18% from that price, and the wider picture remains bruising: the shares have shed more than half their value over the past twelve months, closing near €9.16 in European trading while the annualized dividend yield hovers around 15.6%.
That yield is a magnet for income seekers, but the numbers behind it are raising red flags. The business development company reported first‑quarter earnings per share of $0.41, missing the $0.44 consensus. Revenue slumped to $304 million, a 24% drop from the prior year and well shy of the $316.81 million analysts had penciled in. For a BDC that relies on steady income from its credit and equity portfolio, the revenue decline is particularly sensitive—it puts the sustainability of the payout under a microscope.
The trouble had already surfaced in February. The company disclosed that its net asset value had slipped to $20.89 per share, a 5% decline, as the overall value of the investment portfolio shrank. The stock cratered more than 15% in a single trading session. Since then, the shares have continued to erode, now trading at roughly half the 52‑week high of $19.38. Year‑to‑date, the loss stands at about 28%.
Should investors sell immediately? Or is it worth buying FS KKR Capital?
The dividend itself has been trimmed. The most recent quarterly payment came in at $0.42 per share, down from $0.48 in March 2026. That translates to an annualized distribution of $1.68 per share, or the hefty yield that still attracts attention—and skepticism. Analysts are cautious, with a consensus rating of “Reduce” and a price target of $10.58, based on seven hold ratings and one sell. The market appears to be discounting the possibility that the payout will be harder to earn going forward.
Legal pressures are compounding the operational strain. A securities class‑action lawsuit has been filed, with lead‑plaintiff applications due by July 6, 2026. The suit, flagged by Rosen Law Firm and Schall Law Firm, targets statements made between May 8, 2024 and February 25, 2026 concerning the efficiency of a portfolio restructuring, the valuation of investments, and the long‑term viability of the dividend strategy.
The next key event on the calendar is the ex‑dividend date of June 17, with the $0.42 payment scheduled for July 2. That will offer a near‑term test of whether the combination of a high yield, shrinking revenues, and litigation can attract enough buyers to stabilize the stock. For now, the insider purchase provides a flicker of internal conviction, but it will take more than one director’s bet to turn the broader narrative around.
Ad
FS KKR Capital Stock: Buy or Sell?! New FS KKR Capital Analysis from May 19 delivers the answer:
The latest FS KKR Capital figures speak for themselves: Urgent action needed for FS KKR Capital investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from May 19.
FS KKR Capital: Buy or sell? Read more here...
